A large study of US veterans suggests that diabetes and weight-loss medicines may curb cravings and lower severe addiction ...

My team and I set out to test whether GLP-1 drugs — medications like semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound), originally developed for diabetes and then approved for ...

A new study reports that GLP-1 semaglutide medications may help reverse the effects of osteoarthritis in the joints by ...

A growing body of research has looked at GLP-1 drugs for alcohol use disorder. A new study shows the medications could have a ...

GLP-1 drugs, like semaglutide, may help people avoid developing addictions to alcohol, tobacco, and drugs such as cannabis ...

A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction—and help people who already have one, a new study shows.

Meanwhile, Eli Lilly has launched an Employer Contract, its direct-to-employer platform for GLP-1s. Plus, researchers find that most patients can keep the weight off with less frequent GLP-1 shots.

Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be effective at treating and preventing substance use disorders across all major ...

Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

A new study found GLP-1 drugs were associated with 50% fewer substance-related deaths, 39% fewer drug overdoses, and 26% ...

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didnt ...